These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12720065)

  • 1. A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response.
    Pearlstein T; Spurell E; Hohlstein LA; Gurney V; Read J; Fuchs C; Keller MB
    Arch Womens Ment Health; 2003 Apr; 6(2):147-51. PubMed ID: 12720065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.
    Hudson JI; McElroy SL; Raymond NC; Crow S; Keck PE; Carter WP; Mitchell JE; Strakowski SM; Pope HG; Coleman BS; Jonas JM
    Am J Psychiatry; 1998 Dec; 155(12):1756-62. PubMed ID: 9842788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.
    McElroy SL; Hudson JI; Malhotra S; Welge JA; Nelson EB; Keck PE
    J Clin Psychiatry; 2003 Jul; 64(7):807-13. PubMed ID: 12934982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of bulimia nervosa and binge eating disorder.
    Walsh BT; Devlin MJ
    Addict Behav; 1995; 20(6):757-64. PubMed ID: 8820528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.
    Arnold LM; McElroy SL; Hudson JI; Welge JA; Bennett AJ; Keck PE
    J Clin Psychiatry; 2002 Nov; 63(11):1028-33. PubMed ID: 12444817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial.
    Milano W; Siano C; Putrella C; Capasso A
    Adv Ther; 2005; 22(3):278-83. PubMed ID: 16236688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study.
    Ricca V; Mannucci E; Mezzani B; Moretti S; Di Bernardo M; Bertelli M; Rotella CM; Faravelli C
    Psychother Psychosom; 2001; 70(6):298-306. PubMed ID: 11598429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
    Hollander E; Koran LM; Goodman WK; Greist JH; Ninan PT; Yang H; Li D; Barbato LM
    J Clin Psychiatry; 2003 Jun; 64(6):640-7. PubMed ID: 12823077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.
    Appolinario JC; Bacaltchuk J; Sichieri R; Claudino AM; Godoy-Matos A; Morgan C; Zanella MT; Coutinho W
    Arch Gen Psychiatry; 2003 Nov; 60(11):1109-16. PubMed ID: 14609886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.
    Asnis GM; Hameedi FA; Goddard AW; Potkin SG; Black D; Jameel M; Desagani K; Woods SW
    Psychiatry Res; 2001 Aug; 103(1):1-14. PubMed ID: 11472786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder.
    Rinne T; van den Brink W; Wouters L; van Dyck R
    Am J Psychiatry; 2002 Dec; 159(12):2048-54. PubMed ID: 12450955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder.
    Westenberg HG; Stein DJ; Yang H; Li D; Barbato LM
    J Clin Psychopharmacol; 2004 Feb; 24(1):49-55. PubMed ID: 14709947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eating Disorder Examination-Questionnaire as a measure of change in patients with bulimia nervosa.
    Sysko R; Walsh BT; Fairburn CG
    Int J Eat Disord; 2005 Mar; 37(2):100-6. PubMed ID: 15732070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.
    Riddle MA; Reeve EA; Yaryura-Tobias JA; Yang HM; Claghorn JL; Gaffney G; Greist JH; Holland D; McConville BJ; Pigott T; Walkup JT
    J Am Acad Child Adolesc Psychiatry; 2001 Feb; 40(2):222-9. PubMed ID: 11211371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study.
    Zheng H; Jia F; Han H; Wang S; Guo G; Quan D; Li G; Huang H
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):397-404. PubMed ID: 30595354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial.
    White MA; Grilo CM
    J Clin Psychiatry; 2013 Apr; 74(4):400-6. PubMed ID: 23656848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
    Stein MB; Fyer AJ; Davidson JR; Pollack MH; Wiita B
    Am J Psychiatry; 1999 May; 156(5):756-60. PubMed ID: 10327910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open trial of fluvoxamine in the treatment of bulimia nervosa.
    Ayuso-Gutierrez JL; Palazón M; Ayuso-Mateos JL
    Int J Eat Disord; 1994 Apr; 15(3):245-9. PubMed ID: 8199604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study.
    Milano W; Petrella C; Casella A; Capasso A; Carrino S; Milano L
    Adv Ther; 2005; 22(1):25-31. PubMed ID: 15943219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.
    Zanardi R; Franchini L; Serretti A; Perez J; Smeraldi E
    J Clin Psychiatry; 2000 Jan; 61(1):26-9. PubMed ID: 10695642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.